Literature DB >> 11683974

Prostate adenocarcinoma producing syndrome of inappropriate secretion of antidiuretic hormone.

T Yamazaki1, H Suzuki, T Tobe, N Sekita, H Kito, T Ichikawa, K Akakura, T Igarashi, H Ito.   

Abstract

The syndrome of inappropriate secretion of antidiuretic hormone (ADH) was recognized in a 68-year-old man with a poorly differentiated metastatic adenocarcinoma of the prostate. Elevated levels of ADH were found in the tissues of the primary tumor and lymph node metastasis. The patient's clinical course is detailed and the pathophysiology of this syndrome is discussed. To our knowledge, this case is the ninth reported case of syndrome of inappropriate secretion of ADH with adenocarcinoma of the prostate. Antidiuretic hormone activity was proven in only three cases including this case.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11683974     DOI: 10.1046/j.1442-2042.2001.00362.x

Source DB:  PubMed          Journal:  Int J Urol        ISSN: 0919-8172            Impact factor:   3.369


  8 in total

1.  SIADH associated with prostate cancer.

Authors:  Kyun Sang Lee; Taek Won Kang; Seong Kwon Ma; Soo Wan Kim; Nam Ho Kim; Ki Chul Choi
Journal:  Electrolyte Blood Press       Date:  2007-06-30

Review 2.  Diagnosis and management of isolated pituitary metastasis from adenocarcinoma of unknown origin presenting as loss of libido.

Authors:  Julien Feghaly; George Astras
Journal:  BMJ Case Rep       Date:  2015-03-31

Review 3.  Paraneoplastic syndromes in prostate cancer.

Authors:  Matthew K Hong; Jennifer Kong; Benjamin Namdarian; Anthony Longano; Jeremy Grummet; Christopher M Hovens; Anthony J Costello; Niall M Corcoran
Journal:  Nat Rev Urol       Date:  2010-12       Impact factor: 14.432

4.  Oxytocin induces the migration of prostate cancer cells: involvement of the Gi-coupled signaling pathway.

Authors:  Miao Zhong; Maryam L Boseman; Ana C Millena; Shafiq A Khan
Journal:  Mol Cancer Res       Date:  2010-07-27       Impact factor: 5.852

5.  Exploiting Dependence of Castration-Resistant Prostate Cancer on the Arginine Vasopressin Signaling Axis by Repurposing Vaptans.

Authors:  Laine M Heidman; Nahuel Peinetti; Valeria A Copello; Kerry L Burnstein
Journal:  Mol Cancer Res       Date:  2022-08-05       Impact factor: 6.333

6.  Unusual metastatic features in a patient with concomitant malignant orbital melanoma and prostate carcinoma.

Authors:  Catherine Ars; Lionel Duck; Jean-Francois Baurain; Pierre Moulin; Thierry Duprez; Jean-Pascal Machiels
Journal:  J Neurooncol       Date:  2004-02       Impact factor: 4.130

7.  Inappropriate antidiuretic hormone syndrome presenting as ectopic antidiuretic hormone-secreting gastric adenocarcinoma: a case report.

Authors:  Kyungo Hwang; Dae-Hong Jeon; Ha Nee Jang; Eun Jin Bae; Jong Sil Lee; Hyun Seop Cho; Se-Ho Chang; Dong Jun Park
Journal:  J Med Case Rep       Date:  2014-06-12

8.  Peptide Agonists of Vasopressin V2 Receptor Reduce Expression of Neuroendocrine Markers and Tumor Growth in Human Lung and Prostate Tumor Cells.

Authors:  Marina Pifano; Juan Garona; Carla S Capobianco; Nazareno Gonzalez; Daniel F Alonso; Giselle V Ripoll
Journal:  Front Oncol       Date:  2017-01-30       Impact factor: 6.244

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.